How DEPLIN® Addresses the Unmet Need in MDD
How Clinical Evidence Supports DEPLIN®
as Adjunctive Therapy in MDD
How DEPLIN® Works
-
How DEPLIN® Addresses the Unmet Need in MDD
Watch Dr Andrew Cutler, Chief Medical Officer of Meridien Research in Bradenton, Florida, discuss the unmet need in major depressive disorder (MDD) and how DEPLIN® can help.
-
How Clinical Evidence Supports DEPLIN® as Adjunctive Therapy in MDD
Watch Dr Andrew Cutler, Chief Medical Officer of Meridien Research in Bradenton, Florida, present the clinical evidence supporting DEPLIN® as adjunctive therapy in MDD.
-
How DEPLIN® Works
Watch how the active folate found in DEPLIN®, L-methylfolate, crosses the blood-brain barrier and is thought to help enhance production of the neurotransmitters required by many patients to help achieve and maintain the benefits of antidepressants.